Publications by authors named "Jeba Ajgar Ansari"
Article Synopsis
- * Despite their promise, there's a lack of comprehensive literature summarizing their applications and challenges, such as identifying disease targets and improving SeNP stability and distribution.
- * Recent efforts have focused on advancing SeNP functionalization methods and mechanisms for biomedical uses, highlighting their potential in cancer treatment and as a support against viral infections like COVID-19.
Background: The development of breast cancer (BC) and how it responds to treatment have both been linked to the involvement of inflammation. Chronic inflammation is critical in carcinogenesis, leading to elevated DNA damage, impaired DNA repair machinery, cell growth, apoptosis, angiogenesis, and invasion. Studies have found several targets that selectively modulate inflammation in cancer, limit BC's growth, and boost treatment effectiveness.
View Article and Find Full Text PDFBreast cancer (BC) is among the most frequent malignancies women face around the globe. Nanotherapeutics are constantly evolving to overcome the limitations of conventional diagnostic and therapeutic approaches. Nanotechnology-based nanocarriers have a higher entrapment efficiency, low cytotoxicity, greater stability and improved half-life than conventional therapy.
View Article and Find Full Text PDF